tiprankstipranks
Advertisement
Advertisement
Novartis to Acquire Myricx Bio for $1.5B to Boost Cancer Drugs; NVS Stock Falls
PremiumMarket NewsNovartis to Acquire Myricx Bio for $1.5B to Boost Cancer Drugs; NVS Stock Falls
14d ago
Novartis agrees to acquire Myricx Bio for up to $1.5B
Premium
The Fly
Novartis agrees to acquire Myricx Bio for up to $1.5B
14d ago
Novartis to acquire Myricx Bio for $1.1B upfront
Premium
The Fly
Novartis to acquire Myricx Bio for $1.1B upfront
14d ago
SCHD vs. VYMI vs. JEPI: Which Is the Best Dividend ETF for Steady Passive Income?
PremiumMarket NewsSCHD vs. VYMI vs. JEPI: Which Is the Best Dividend ETF for Steady Passive Income?
28d ago
BTIG says others may be interested in Apogee Therapeutics
Premium
The Fly
BTIG says others may be interested in Apogee Therapeutics
28d ago
CMS proposes to lock in lower prices in Medicare drug price negotiation program
Premium
The Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
1M ago
Novartis announces biomarker cohort in study of del-brax met primary endpoint
PremiumThe FlyNovartis announces biomarker cohort in study of del-brax met primary endpoint
1M ago
Novartis, Orionis enter collaboration for molecular glue medicines
Premium
The Fly
Novartis, Orionis enter collaboration for molecular glue medicines
1M ago
Acting FDA head vows to block political interference, Endpoint News says
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100